Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population

Medicine and Dentistry

• Patient 100%
• Glycogen Storage Disease Type II 80%
• Glucan 1,4 Alpha Glucosidase 30%
• Weakness 30%
• Mass Screening 20%
• Heterozygote 20%
• Myopathy 20%
• Dried Blood Spot 20%
• Diagnosis 10%
• Leukocyte 10%
• Enzyme Activity 10%
• Clinical Feature 10%
• Screening 10%
• Final Diagnosis 10%
• Health Care Cost 10%
• Clinical Finding 10%
• Analysis 10%
• Early Diagnosis 10%

Biochemistry, Genetics and Molecular Biology

• Allele 30%
• Acid Alpha-Glucosidase 30%
• Mass Screening 20%
• Enzyme Activity 10%
• Mutation 10%
• Screening 10%
• Genetic Carrier 10%
• Leukocytes 10%
• Dried Blood Spot 10%
• Time 10%